Market Cap 7.14B
Revenue (ttm) 634.44M
Net Income (ttm) -25.51M
EPS (ttm) N/A
PE Ratio 90.14
Forward PE 78.87
Profit Margin -4.02%
Debt to Equity Ratio 0.00
Volume 863,600
Avg Vol 682,498
Day's Range N/A - N/A
Shares Out 56.15M
Stochastic %K 17%
Beta 0.95
Analysts Strong Sell
Price Target $188.80

Latest News on RGEN

Repligen: Ongoing Bioprocessing Market Recovery

Mar 20, 2025, 7:52 AM EDT - 13 days ago

Repligen: Ongoing Bioprocessing Market Recovery


Repligen Corporation (RGEN) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 2:53 PM EST - 5 weeks ago

Repligen Corporation (RGEN) Q4 2024 Earnings Call Transcript


Repligen Launches the CTech™ SoloVPE® PLUS System

Jan 6, 2025, 7:30 AM EST - 3 months ago

Repligen Launches the CTech™ SoloVPE® PLUS System


Repligen Corporation (RGEN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 3:07 PM EST - 5 months ago

Repligen Corporation (RGEN) Q3 2024 Earnings Call Transcript


Repligen Corporation (RGEN) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 3:03 PM EDT - 8 months ago

Repligen Corporation (RGEN) Q2 2024 Earnings Call Transcript


Repligen Lowers Guidance On China Weakness, Analyst Expects

Jul 30, 2024, 12:01 PM EDT - 8 months ago

Repligen Lowers Guidance On China Weakness, Analyst Expects


Repligen Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 7:30 AM EDT - 8 months ago

Repligen Reports Second Quarter 2024 Financial Results


Repligen to Report Second Quarter 2024 Financial Results

Jul 16, 2024, 7:30 AM EDT - 9 months ago

Repligen to Report Second Quarter 2024 Financial Results


Top 3 Health Care Stocks That Could Blast Off In June

Jun 21, 2024, 8:22 AM EDT - 10 months ago

Top 3 Health Care Stocks That Could Blast Off In June

ENOV PEN


Repligen Announces CEO Transition Plan

Jun 13, 2024, 7:00 AM EDT - 10 months ago

Repligen Announces CEO Transition Plan


Repligen Reports First Quarter 2024 Financial Results

May 1, 2024, 7:30 AM EDT - 1 year ago

Repligen Reports First Quarter 2024 Financial Results


Repligen to Report First Quarter 2024 Financial Results

Apr 17, 2024, 7:30 AM EDT - 1 year ago

Repligen to Report First Quarter 2024 Financial Results


Repligen Appoints Maggie A. Pax to Board of Directors

Mar 19, 2024, 7:30 AM EDT - 1 year ago

Repligen Appoints Maggie A. Pax to Board of Directors


Repligen Corporation (RGEN) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 2:35 PM EST - 1 year ago

Repligen Corporation (RGEN) Q4 2023 Earnings Call Transcript


Repligen Corporation (RGEN) Q3 2023 Earnings Call Transcript

Oct 31, 2023, 1:16 PM EDT - 1 year ago

Repligen Corporation (RGEN) Q3 2023 Earnings Call Transcript


Repligen to Report Third Quarter 2023 Financial Results

Oct 17, 2023, 7:30 AM EDT - 1 year ago

Repligen to Report Third Quarter 2023 Financial Results


Repligen Corporation (RGEN) Q2 2023 Earnings Call Transcript

Aug 2, 2023, 3:26 PM EDT - 1 year ago

Repligen Corporation (RGEN) Q2 2023 Earnings Call Transcript